Position history for BlackRock, Inc.'s holdings in ARROWHEAD PHARMACEUTICALS IN
BlackRock, Inc. holds 18.2M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $1.1B as of 2026-Q1. The position was decreased (-14.8% shares). ARWR represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$1.1B
Current Shares
18.2M
Total Value Change
+$834.6M
Total Shares Change
+2M
Other major holders of ARWR: VANGUARD GROUP INC, Avoro Capital Advisors LLC, FMR LLC
Decreased |
| 18.2M |
-14.8% |
| $1.1B |
| 0.0% |
| $64.10 |
0 |
| 2025-Q4 | Increased | 21.3M | +5.4% | $1.4B | 0.0% | $67.25 | 34 |
| 2025-Q3 | Increased | 20.2M | +4.1% | $697.6M | 0.0% | $33.78 | 33 |
| 2025-Q2 | Decreased | 19.4M | -2.5% | $306.9M | 0.0% | $16.08 | 0 |
| 2025-Q1 | Increased | 19.9M | +23.2% | $253.9M | 0.0% | $13.82 | 37 |
| 2024-Q4 | New | 16.2M | - | $304.1M | 0.0% | $18.61 | 43 |